Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · IEX Real-Time Price · USD
2.390
-0.030 (-1.24%)
At close: Mar 28, 2024, 4:00 PM
2.380
-0.010 (-0.42%)
After-hours: Mar 28, 2024, 7:54 PM EDT

Coherus BioSciences Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Coherus BioSciences stock have an average target of 9.20, with a low estimate of 7.00 and a high estimate of 11. The average target predicts an increase of 284.94% from the current stock price of 2.39.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $9.20 $9.00 $11
Change +192.89% +284.94% +276.57% +360.25%

Analyst Ratings

The average analyst rating for CHRS stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 433333
Buy 122222
Hold 111111
Sell 000000
Strong Sell 000000
Total 666666

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$13$11
Strong Buy Maintains $13$11 +360.25% Mar 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$13
Strong Buy Reiterates $13 +443.93% Mar 14, 2024
Baird
Baird
Buy
Maintains
$11$9
Buy Maintains $11$9 +276.57% Jan 23, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$12$8
Strong Buy Maintains $12$8 +234.73% Jan 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$13
Strong Buy Reiterates $13 +443.93% Dec 27, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
353.86M
from 257.24M
Increased by 37.56%
Revenue Next Year
444.46M
from 353.86M
Increased by 25.60%
EPS This Year
-0.25
from -2.53
EPS Next Year
0.02
from -0.25
Year 2019202020212022202320242025202620272028
Revenue
356.07M475.82M326.55M211.04M257.24M353.86M444.46M751.22M818.01M840.31M
Revenue Growth
-33.63%-31.37%-35.37%21.89%37.56%25.60%69.02%8.89%2.73%
EPS
1.231.62-3.81-3.76-2.53-0.250.021.121.821.62
EPS Growth
-31.71%-----7,103.95%62.56%-10.96%
No. Analysts -----1111444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 431.6M 669.5M 945.0M 1.1B 1.2B
Avg 353.9M 444.5M 751.2M 818.0M 840.3M
Low 237.2M 245.0M 585.5M 619.2M 630.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
67.8%
89.2%
112.6%
47.5%
41.2%
Avg
37.6%
25.6%
69.0%
8.9%
2.7%
Low
-7.8%
-30.8%
31.7%
-17.6%
-22.9%

EPS Forecast

EPS 20242025202620272028
High 0.38 0.48 1.54 2.17 2.34
Avg -0.25 0.02 1.12 1.82 1.62
Low -0.75 -0.57 0.71 1.46 0.92

EPS Growth

EPS Growth 20242025202620272028
High - -
9,855.5%
94.6%
29.0%
Avg - -
7,103.9%
62.6%
-11.0%
Low - -
4,451.1%
30.7%
-49.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.